Shariatga muvofiqlik sharhi
Halol emasAvalyn Pharma Inc. Common Stock (AVLN) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol emas deb tasniflanadi.
Avalyn Pharma Inc. Common Stock haqida
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs).
Avalyn Pharma Inc. Common Stock (AVLN) Healthcare sektorida, Biotechnology sohasida faoliyat yuritadi.
Nega halol deb hisoblanmaydi: aksiya quyidagi tekshiruvlardan o'tmaydi: Kompaniya faoliyati.
- Kompaniya faoliyati
- 100.00%Chegara 5%Muvaffaq emas
- Foizli qarz
- 0.00%Chegara 30%Muvaffaq
- Foizli qimmatli qog‘ozlar va aktivlar
- 10.28%Chegara 30%Muvaffaq
- Dividendlarni poklash
- 100.00%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori
Oxirgi yangilanish: 3-noy, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kompaniya profili
Kontentni ko'rish uchun tizimga kiring
Tez-tez beriladigan savollar
Avalyn Pharma Inc. Common Stock (AVLN) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol emas.
